Blog

Alan Ka-Lun Kai: Navigating EGFR resistance in the AsiaPac region

Alan Ka-Lun Kai/LinkedIn

Dec 5, 2024, 23:04

Alan Ka-Lun Kai: Navigating EGFR resistance in the AsiaPac region

Alan Ka-Lun Kai, Director, Head of Medical Affairs and Operation Excellence, posted the following on LinkedIn:

“EGFR resistance in lung cancer is an extremely important topic particularly in our AsiaPac region where the prevalence of EGFR is especially high compared to the rest of the world. It’s our great honour to have these highly scientific gentlemen Antonio Passaro, Herbert Loong, Molly Li, Nyaw Shi Feng to navigate the complexity of EGFR resistance with us together during IOHK. We are committed to transform patients’ lives further with you altogether.”

Alan Ka-Lun KAI Antonio Passaro AsiaPac region Cancer research EGFR resistance Herbert Loong IOHK Lung cancer lung cancer treatment Molly Li Nyaw Shi Feng OncoDaily Oncology patient transformation

Stanley Tucci and Throat Cancer: How He Went Against, How He Survived, and More

Senator John Fetterman Responds to Oncodaily on Pediatric Oncology Funding

Does Processed Meat Cause Cancer? Myths and Facts

Global Health Dialogues with Princess Dina Mired | Episode 1: Dr. Firas Al-Hawari

NEW PAPER ALERT: ESOPEC trial on Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer